FDA Committee To Review WHO's Antimalarial Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
The World Health Organization is seeking approval of artesunate rectal suppositories as an initial treatment for those living in remote locations.You may also be interested in...
WHO Closer To FDA Approval For Malaria Drug
FDA has been holding the world body to the same standards it uses for a regular drug review, resulting in many years of delay in bringing artesunate rectal suppositories to market - but the Anti-Infective Drugs Advisory Committee has given a partial endorsement.
WHO Closer To FDA Approval For Malaria Drug
FDA has been holding the world body to the same standards it uses for a regular drug review, resulting in many years of delay in bringing artesunate rectal suppositories to market - but the Anti-Infective Drugs Advisory Committee has given a partial endorsement.
WHO's Malaria Drug Gets A Second Chance At Advisory Committee
The World Health Organization is hoping advisory committee approval of its artesunate rectal suppositories to treat malaria will help it overcome a long and rocky regulatory path with FDA.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: